Dr. Tijana Fazlagic is the Executive Director of Therapeutic Assessment & Access, part of the Pharmaceutical, Laboratory & Blood Services Division at the British Columbia Ministry of Health. Dr. Fazlagic’s responsibilities include leadership of the formulary management, specialty medicines, precision medicine and genetic services and the business team. Dr. Fazlagic represents BC on various committees including the Canadian Agency for Drugs and Technologies in Health and pan-Canadian Pharmaceutical Alliance. Dr. Fazlagic holds a Doctor of Pharmacy degree from the University of Florida, a Master of Science and a Bachelor of Science degrees in Pharmacy from the University of Saskatchewan.
Day 1 Oct 28, 2025
3:00 pm
PANEL
From Simply Price to Stronger Partnerships: Getting to “Yes” Across the Lifecycle
Join this conversation to gain insights on working together on access pathways that support sustainable access for patients.
With more diverse approaches to manage drug budgets while still ensuring critical medicines are accessible to patients, this discussion will explore practical ways to work together on streamlining negotiations, considering a broader lifecycle mindset, and ultimately, creating shared value for all parties.
You’ll return with strategies to:
- Navigate pricing frameworks: demystify different approaches and criteria across the Canadian landscape
- Consider lifecycle planning: align evidence, value propositions, and timing from launch through maturity to support payer discussions
- Find common ground: discuss where policies align, tailor where they diverge, and build collaborative tactics that balance cost containment with equitable, timely patient access
Day 2 Oct 29, 2025
